| 0703-4094 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Teva Parenteral Medicines, Inc. |
| 0703-4094-01 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Teva Parenteral Medicines, Inc. |
| 0781-3312 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HCl injection, for intravenous use Initial U.S. Approval: 2003 | Sandoz Inc |
| 0781-3312-75 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HCl injection, for intravenous use Initial U.S. Approval: 2003 | Sandoz Inc |
| 0781-3312-95 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HCl injection, for intravenous use Initial U.S. Approval: 2003 | Sandoz Inc |
| 0781-3415 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HCl injection, for intravenous use Initial U.S. Approval: 2003 | Sandoz Inc |
| 0781-3415-75 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HCl injection, for intravenous use Initial U.S. Approval: 2003 | Sandoz Inc |
| 0781-3415-95 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HCl injection, for intravenous use Initial U.S. Approval: 2003 | Sandoz Inc |
| 16714-834 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | NorthStar Rx LLC | Gland Pharma Limited |
| 16714-834-01 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | NorthStar Rx LLC | Gland Pharma Limited |
| 25021-783 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Sagent Pharmaceuticals |
| 25021-783-05 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Sagent Pharmaceuticals |
| 36000-326 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Baxter Healthcare Corporation |
| 36000-326-01 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Baxter Healthcare Corporation |
| 36000-326-02 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Baxter Healthcare Corporation |
| 55111-694 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Dr.Reddy's Laboratories Limited | Gland Pharma Limited |
| 55111-694-07 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Dr.Reddy's Laboratories Limited | Gland Pharma Limited |
| 55111-694-15 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Dr.Reddy's Laboratories Limited | Gland Pharma Limited |
| 55111-694-19 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Dr.Reddy's Laboratories Limited | Gland Pharma Limited |
| 55150-186 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Eugia US LLC | EUGIA PHARMA SPECIALITIES LIMITED |
| 55150-186-05 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Eugia US LLC | EUGIA PHARMA SPECIALITIES LIMITED |
| 58063-797 | ALOXI ® (palonosetron HCl) Injection for Intravenous Use | MGI PHARMA |
| 58063-797-25 | ALOXI ® (palonosetron HCl) Injection for Intravenous Use | MGI PHARMA |
| 58063-797-37 | ALOXI ® (palonosetron HCl) Injection for Intravenous Use | MGI PHARMA |
| 58063-797-99 | ALOXI ® (palonosetron HCl) Injection for Intravenous Use | MGI PHARMA |
| 60505-6193 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Apotex Corp. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 60505-6193-1 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Apotex Corp. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 60505-6193-4 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Apotex Corp. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 60505-6439 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Apotex Corp. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 60505-6439-1 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Apotex Corp. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 63323-673 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE Injection, for intravenous use Initial U.S. Approval: 2003 | Fresenius Kabi USA, LLC | Fresenius Kabi Austria |
| 63323-673 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE Injection, for intravenous use Initial U.S. Approval: 2003 | Fresenius Kabi USA, LLC | Fresenius Kabi Austria |
| 63323-673-05 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE Injection, for intravenous use Initial U.S. Approval: 2003 | Fresenius Kabi USA, LLC | Fresenius Kabi Austria |
| 63323-673-21 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE Injection, for intravenous use Initial U.S. Approval: 2003 | Fresenius Kabi USA, LLC | Fresenius Kabi Austria |
| 63323-673-89 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE Injection, for intravenous use Initial U.S. Approval: 2003 | Fresenius Kabi USA, LLC | Fresenius Kabi Austria |
| 67184-0514 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 67184-0514-1 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 67184-0515 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 67184-0515-1 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 67184-0515-2 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 67457-317 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION . PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Mylan Institutional LLC |
| 67457-317-25 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION . PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Mylan Institutional LLC |
| 68001-355 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | BluePoint Laboratories | Dr.Reddy's Laboratories Limited | Gland Pharma Limited |
| 68001-355-25 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | BluePoint Laboratories | Dr.Reddy's Laboratories Limited | Gland Pharma Limited |
| 69097-927 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION<BR><BR>Palonosetron Hydrochloride Injection, for Intravenous Use<BR>Initial U.S. Approval: 2003 | Cipla USA Inc. | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals Limited | Pierre Fabre Medicament Production | Oso Bio Pharmaceutical Manufacturing, LLC |
| 69097-927-35 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION<BR><BR>Palonosetron Hydrochloride Injection, for Intravenous Use<BR>Initial U.S. Approval: 2003 | Cipla USA Inc. | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals Limited | Pierre Fabre Medicament Production | Oso Bio Pharmaceutical Manufacturing, LLC |
| 69639-101 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Baxter Oncology GmbH |
| 69639-101 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Patheon Italia S.p.A. | Baxter Oncology GmbH |
| 69639-101-01 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Baxter Oncology GmbH |
| 69639-101-01 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Patheon Italia S.p.A. | Baxter Oncology GmbH |
| 69639-101-04 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Baxter Oncology GmbH |
| 69639-101-04 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Patheon Italia S.p.A. | Baxter Oncology GmbH |
| 69639-102 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Baxter Oncology GmbH |
| 69639-102 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Patheon Italia S.p.A. | Baxter Oncology GmbH |
| 69639-102-01 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Patheon Italia S.p.A. | Baxter Oncology GmbH |
| 69639-102-01 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Baxter Oncology GmbH |
| 69639-105 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Patheon Italia S.p.A. | Baxter Oncology GmbH |
| 69639-105 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Baxter Oncology GmbH |
| 69639-105-01 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Baxter Oncology GmbH |
| 69639-105-01 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Patheon Italia S.p.A. | Baxter Oncology GmbH |
| 69639-106 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Baxter Oncology GmbH |
| 69639-106 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Patheon Italia S.p.A. | Baxter Oncology GmbH |
| 69639-106-01 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Baxter Oncology GmbH |
| 69639-106-01 | These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018 | Helsinn Therapeutics (U.S.), Inc. | Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Birex Pharmaceuticals LTD | Patheon Italia S.p.A. | Baxter Oncology GmbH |
| 71288-409 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Meitheal Pharmaceuticals Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. |
| 71288-409-05 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Meitheal Pharmaceuticals Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. |
| 83634-777 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Avenacy, Inc. |
| 83634-777-05 | These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION. PALONOSETRON HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 2003 | Avenacy, Inc. |
| 83831-104 | These highlights do not include all the information needed to use POSFREA safely and effectively. See full prescribing information for POSFREA. POSFREA TM (palonosetron) injection, for intravenous use Initial U.S. Approval: 2003 | Avyxa Pharma, LLC | Avyxa Holdings, LLC. |
| 83831-104-05 | These highlights do not include all the information needed to use POSFREA safely and effectively. See full prescribing information for POSFREA. POSFREA TM (palonosetron) injection, for intravenous use Initial U.S. Approval: 2003 | Avyxa Pharma, LLC | Avyxa Holdings, LLC. |
| 83831-105 | These highlights do not include all the information needed to use POSFREA safely and effectively. See full prescribing information for POSFREA. POSFREA TM (palonosetron) injection, for intravenous use Initial U.S. Approval: 2003 | Avyxa Pharma, LLC | Avyxa Holdings, LLC. |
| 83831-105-01 | These highlights do not include all the information needed to use POSFREA safely and effectively. See full prescribing information for POSFREA. POSFREA TM (palonosetron) injection, for intravenous use Initial U.S. Approval: 2003 | Avyxa Pharma, LLC | Avyxa Holdings, LLC. |